<DOC>
	<DOCNO>NCT00271167</DOCNO>
	<brief_summary>The purpose study assess safety INO-1001 , intravenous PARP ( poly- [ ADP ribose ] polymerase ) inhibitor , patient undergo heart surgery . The study also measure whether INO-1001 reduces side effect cause heart-lung bypass machine .</brief_summary>
	<brief_title>A Trial INO-1001 Patients Undergoing Heart Surgery That Involves Heart-lung Bypass</brief_title>
	<detailed_description>Heart-lung bypass heart surgery sometimes lead side effect complication surgery . Studies show PARP inhibitor protect cell damage due lack oxygen . Heart-lung bypass heart surgery result cell deprive oxygen . INO-1001 may able protect cell reduce complication follow surgery . A total 162 patient randomly assign either INO-1001 placebo ( sugar water ) . Treatment begin day heart surgery continue 36 hour . A total 4 dos INO-1001 give . Patients follow 30 day surgery . The following information collect : symptom , vital sign , physical examination , blood urine test , electrocardiogram , information medical chart . The information provide listing disclose solely comply regulatory requirement . The drug INO-1001 yet approve marketing available patient participate clinical trial chosen treatment group .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Patients schedule undergo cardiopulmonary bypass coronary revascularization and/or valve surgery Males nonpregnant , nonlactating female Subjects require undergo full medical review order exclude serious medical psychological illness prior inclusion History hypersensitivity reaction three drug mannitol Participation investigational study within 30 day screen phase Known alcohol drug abuse within last year Treatment certain restrict medication within specified time prior participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>PARP inhibitor</keyword>
	<keyword>PARP inhibition</keyword>
	<keyword>Bypass surgery</keyword>
	<keyword>CPB surgery</keyword>
	<keyword>Cardiopulmonary bypass</keyword>
	<keyword>Coronary revascularization</keyword>
	<keyword>Cardiac valve replacement</keyword>
</DOC>